Nicotine Addiction and Smoking: Health Effects and Interventions (Nursing)


Learning Outcome

  • Analyze the dangers of tobacco abuse and it effect on the health of tobacco users.
  • Demonstrate evidence-based practice assessment of tobacco use.
  • Utilize multiple interventions to assist tobacco users to quit smoking.
  • Analyze methods to prevent children and adolescents from becoming tobacco users.
  • Practice advocacy to assist communities and populations to control tobacco use through political, social, and psychological methods. 
  • Evaluate methods for individuals and communities to avoid exposure to second-hand smoke. 

Introduction

The leaves of the tobacco plant were originally harvested and smoked by Native Americans and were introduced to Europe by Christopher Columbus in the 15th century. The botanical name for tobacco, Nicotiana tabacum, is derived from the Jean Nicot, who sent the tobacco leaf to the Queen of France in the 16th century. During the late 18th century, packaged cigarettes and cigars rapidly gained popularity. Although it was suspected in the early 20th century that tobacco was linked to throat and mouth cancers, it was not until 1964 when the US government released the document titled Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. It has since been the prominent topic of most annual Surgeon Generals Reports.

The original report was an objective review of literature that pointed to tobacco use as being causal to a number of deleterious health conditions. There has since been much research conducted, and many new findings regarding the disease-causing aspects of tobacco smoking have been elucidated. Despite the widely published results of this research tobacco smoking-related illnesses remain the leading cause of preventable death in the United States.[1][2][3]

Nursing Diagnosis

There are several nursing diagnoses that can be used for tobacco cessation, such as: 

Ineffective Therapeutic Regimen Management: Pattern of regulating and integrating into daily living a program for the treatment of illness and the sequelae of illness that is unsatisfactory for meeting specific health goals.  Tobacco use is an unsatisfactory daily activity that leads to negative health outcomes.

Anxiety: Vague uneasy feeling of discomfort or dread accompanied by an autonomic response. Withdrawal from nicotine, an addictive substance, can lead to anxiety.

Deficient Knowledge: Absence or deficiency of cognitive information related to specific topic.  Communities, families, and individuals require an understanding of the addictive nature of tobacco use and its accompanied negative health effects.

Impaired Gas Exchange: Excess or deficit in oxygenation and/or carbon dioxide elimination at the alveolar-capillary membrane. Tobacco use damages lung tissue and influences the ability to exchange oxygen at the cellular level in both smokers and in individuals exposed to second-hand smoke.

Ineffective Coping: Inability to form a valid appraisal of the stressors, inadequate choices of practiced responses, and/or inability to use available resources.  Nicotine initially provides a calming effect; thus is used as a stress reliever and taking a smoking break during activities can also be used as a coping mechanism; however, the long term use of a stress relief method such as tobacco leads to increased stressors associated with poor health.

Risk for Infection: At increased risk for being invaded by pathogen organisms. Exposure to tobacco products creates risk of respiratory infection for the smoker and those exposed to second-hand smoke; it is especially harmful to the immature respiratory systems in infants and children.

Short term outcomes should be for the individual to express a desire to quit using tobacco products; to refrain from smoking around others, especially infants and children; and to enroll in a cessation program.  Long term outcomes are to remain tobacco-free, thus eliminating exposure to the individual and others. 

Causes

Tobacco contains nicotine, which is an addictive substance.  Therefore smokers must contend with not only the habit of smoking but also a serious addiction to nicotine.  A habit develops as a smoker's routine when they use cigarettes or tobacco products for stress relief, relaxation, to decrease hunger, or many other reasons.  An addiction to nictoine can occur as soon as the first exposure to nicotine; therefore avoiding tobacco use altogether is important, making prevention a key intervention in tobacco control efforts.

Risk Factors

About 23% of the worldwide population smokes cigarettes. This includes 32% of all males and 7% of all women. Eastern and Southeast Asia have the highest prevalence of smokers in the world with about 45%, while the Caribbean and North American has the lowest prevalence at 20%.[4]

In 2017, the CDC estimates that 19.3% of the United States population over 18 years old uses some tobacco product. About 14% of the total population use cigarettes while the remaining 5% use cigars, electronic cigarettes, smokeless tobacco, or pipes. Furthermore, 24.8% of men smoke cigarettes, while 14.2% of women smoke cigarettes. By age group, smokers represent 18.3% of adults aged 18 to 24 years old, 22.5% of adults aged 25 to 44 years old, 21.3% of adults aged 45 to 64 years old and 11% of adults 65% and older.[5]

Tobacco use in any form—even occasional smoking—causes serious diseases and health problems, including:

  • Several forms of cancer, including cancers of the lung, bladder, kidney, pancreas, mouth, and throat
  • Heart disease and stroke
  • Lung diseases, including emphysema, bronchitis, chronic obstructive pulmonary disease (COPD)
  • Pregnancy complications, including preterm birth, low birth weight, and birth defects
  • Gum disease
  • Vision problems

Secondhand smoke from cigarettes and cigars also causes heart disease and lung cancer in adults and a number of health problems in infants and children, including:

  • Asthma
  • Respiratory infections and reactive airway
  • Ear infections
  • Sudden infant death syndrome (SIDS) 

Assessment

TS history should be routinely obtained from the patient during the admission assessment. Subjective and objective assessment of tobacco use should be included in every focused assessment. Pack-year history provides an estimate the amount cigarettes a patient has consumed over a lifetime and is calculated as packs smoked per day multiplied by the total number of years smoked. Obtaining a pack-year history has shown to be of some value when determining the presence and severity of smoking-related illnesses such as CAD and COPD, as smoking-related cancers have all been linked to increased pack-year history.[6][7][8]

Many assessment findings can be directly or indirectly related to tobacco smoking. Upon admission and with every aseesment be sure to assess the mouth, teeth, and mucous membranes. The scent of tobacco smoke often lingers on the patient's breath and clothing. Auscultation of the lungs may reveal decreased or asynchronous breath sounds. Cardiac exam often reveals an increased resting heart rate when compared to that of non-smokers. Tobacco stains may be present on the skin of the face and fingers. There may be decreased peripheral pulses due to smoking-related peripheral vascular disease.  Chronic smoking can cause voice changes, including a lower pitch and hoarseness.  Fine wrinkles in the face and around the mouth can also be noted in smokers.  [9][10][11]

Evaluation

Primary assessment of tobacco use is self-report during assesment of social history.  Family or significant others may also provide information regarding tobacco use and amount. Self-report may not be reliable; a patient may not understand the amount of tobacco products used; or may deny or minimize the amount when speaking to health care professionals for fear of being chastized for using tobacco. 

Medical Management

Management and control of tobacco use is four-fold:  1) cessation programs, 2) preventing children and adolescents from smoking, 3) preventing exposure to second-hand smoke, and 4) advocacy to change attitudes toward smoking.  Nurses in various roles, such as school nursing, occupational health, community health, obstetrics, medical-surgical, and research are responsible to assess and intervene to decrease the negative health impact of tobacco. 

Tobacco smoking is directly associated with multiple serious health problems that endanger and shorten the life of smokers and those subjected to cigarette smoke.  Special attention must be paid to pregnant tobacco users. Risks for both mom and baby include preterm labor, small for gestational age infants, and a risk for childhood cancers. For an active smoker, quitting smoking has proven to reduce the chances of developing a smoking-related illness.[12][13]

Daily cigarette smokers keep smoking because they are physically addicted to nicotine, a substance that is naturally found in tobacco leaves. Because nicotine is one of the most addictive substances known to man, TS is often very difficult to quit, often requiring repeated attempts at quitting involving various cessation methods. Five nicotine-based medications (gum, lozenges, inhaler, nasal spray, patch) and 2 non-nicotine-based medications (varenicline and bupropion SR) have been shown to aid in long-term smoking cessation. Recent evidence includes a potential role for cytisine and naltrexone. For patients willing to quit, a combination of counseling and one or more the medications has proven more effective than just counseling or medication alone.[14][15][16]

Nursing Management

Brief interventions on admission to the hospital include assessment of tobacco use; offering nicotine replacement while hospitalized, assessing if a patient is interested in cessation and referring them to counselling if needed.   Special attention must be paid to pregant women who use tobacco products. 

Smokers who are addicted to nicotine will have withdrawal symptoms if not allowed to use tobacco products while hospitalized, including anxiety, vertigo, mood swings, and a general feeling of uneasiness.  There may be standing orders for nicotine replacement therapy; or nurses should ask the provider for an order for nicotine replacement, such as a nicotine patch, gum, or lozenges. [17]

Formal cessation classes may be offered in the community.  Nurses who work in community health settings should conduct or arrange cessation classes that are low cost or free of charge to aid smokers to quit using tobacco. Quitlines, cessation aids that are available via phone, are readily accessible throughout the United States. New technology includes social media apps downloaded to electronic devices to provide cessation programs.   Apps and quitlines are convenient for a tobacco user because they can be used at any time and have been shown to be effective at assisting with cessation. _[18]

Nurses, especially nurses in Community Health should be involved in tobacco control, including prevention, second hand smoke avoidance, and advocacy.  Preventing children and adolescents from using tobacco is a primary duty of school nurses because most tobacco users begin smoking prior to the age of 18, leading to a lifetime of nicotine addiction. There are school based programs with various degress of success that have been used in school settings to help children decide not to use nicotine products.   Second hand smoke efforts to restrict public use of tobacco have been largely successful, smoking is no longer allowed in most public venues due to laws restricting exposure to second hand smoke.  On an individual level, parents who smoke must be made aware that they should not smoke in the presence of their children or in closed areas where children are present, such as in a house or motor vehicle.  Advocacy, including public awareness and advocating for anti-tobacco legislation, has been successful in changing attitudes toward tobacco use.  Social acceptance of tobacco use is decreasing through laws requiring a minimum age for purchase of tobacco products and by raising prices of tobacco products through taxation thus creating difficulty for adolescents to aquire tobacco.  Healthy People 2020 and 2030 have declared tobacco use one of the leading health indicators in the United States, with a goal of decreasing tobacco use in the next ten years. 

When To Seek Help

Nurses in various settings are in a unique position to discuss tobacco use with patients. Preventing children and adolescents from initial tobacco use is imperitive.  Admission assessments include assessment of tobacco use; and every smoker should be asked if they wish to quit, then referred to services to aid in cessation.  Apps and quitlines should be encouraged.   Nurses should practice health education with every encounter with each tobacco user, discussing health implications and aids to assist in cessation.

Outcome Identification

Healthy People 2020 has a goal to "Reduce illness, disability, and death related to tobacco use and secondhand smoke exposure."  Planning includes the use of various methods to promote cessation, prevention of tobacco use and second-hand smoke, and advocacy for legislation restricting access to tobacco products.  Nurses are in a unique position to influence tobacco use at the individual and community level; thereby decreasing the ill effects of tobacco use and healthcare costs.

Monitoring

Because tobacco use is determined by self-report, monitoring is also personal.  A nurse can encourage and refer or teach cessation classes; but ultimately the responsibility for cessation relies with the individual. Attitudes toward tobacco use are increasingly becoming negative as laws restricting public use of tobacco are enacted and advertising tobacco products has been restricted; however, tobacco use is still considered a personal choice, followed by an addiction to nicotine that is difficult to stop. 

Coordination of Care

TS is a life-threatening addiction that, if untreated, can cause damage to every organ system in the human body. The best way to avoid a TS related illness is never to start smoking, and the second best way is to stop smoking cigarettes as soon as possible. Helping a patient to stop smoking is one of the most beneficial preventive medicine interventions currently in existence. Nearly every member of the healthcare team may play an important role in the assistance of smoking cessation.

Nurses play a major role in tobacco cessation programs. In some hospitals, nurses are being trained to deliver behavioral and over the counter pharmaceutical interventions to inpatient smokers. These interventions have shown great promise in significantly reducing smoking in certain populations.[19]

Physicians are also at the front lines in the fight against TS. Unfortunately, several studies have shown that brief episodes of physician advice do very little to aid in smoking cessation.[20] It has been demonstrated that individually focused counseling can aid in the patient's cessation of smoking. There is also evidence that physician prescribed or health care team recommended over-the-counter medications can play an effective role in treating these patients.[21] 

Clinical scientists also play a very important role in the fight to end tobacco addiction and tobacco-related disease. They continue to investigate and discover the physiology of tobacco-related illnesses, the effectiveness of tobacco cessation medications and interventions, and study TS related conditions across a broad spectrum of populations. From the toils of scientific research, much about TS has been elucidated and yet society has much to learn.

Health Teaching and Health Promotion

Health promotion and health teaching is four-fold:  promoting cessation in nicotine-addicted individuals, prevention activities targeted toward children and adolescents, avoiding second-hand smoke in public and private venues, and advoacacy to restrict access to tobacco products and attitudes.  Nurses in various roles, including community and hospitals must assess and intervene for eduational needs of individuals and communities.  Individualize a plan for every tobacco user, including short-term and long-term plans for cessation and avoiding exposure to second hand smoke.  Evaluate frequently, reinforcing the need for cessation and promoting health.

Risk Management

All healthcare personnel should refrain from using tobacco products.  Aside from the personal risk to an individual's health; healthcare personnel are role models for healthy behaviors and using tobacco is not an example of good habits. 

Discharge Planning

Discharge planning for all tobacco users should include a patient-centered plan for cessation.  Medications are available to aid in cessation and should be prescribed by the provider.  Nicotine replacement products are available over the counter or through quit-lines.  Counselling is available through various community agencies or by quit lines or through social media apps.  Additionally smokers should have a plan for avoiding second hand smoke exposure to children and significant others. 

Evidence-Based Issues

Prevalence of tobacco use, negative health effects, and effectiveness of cessation methods can be monitored through evidence based practice.  Recent research on all facets of tobacco use should be utilized in the campaign to end suffering and high costs of tobacco use.  Analyze available research for application to populations, interventions, comparisons, outcomes, and time.

Pearls and Other issues

Tobacco use is a preventable cause of morbility and mortality and nurses are in a unique position to assist in the campaign to end suffering from tobacco use and nictoine addiction. Nurses and the entire healthcare team are expected to advocate cessation and prevention in individuals and communitiies through use of evidence based assessments, interventions, and evaluation of the impact of tobacco. 


Details

Nurse Editor

Deb L. Bomgaars

Editor:

Jason Morris

Updated:

8/8/2024 5:28:57 PM

References

[1]

Wipfli H, Samet JM. One Hundred Years in the Making: The Global Tobacco Epidemic. Annual review of public health. 2016:37():149-66. doi: 10.1146/annurev-publhealth-032315-021850. Epub 2016 Jan 14     [PubMed PMID: 26772406]

[2]

Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 Surgeon General's report: "The health consequences of smoking--50 years of progress": a paradigm shift in cancer care. Cancer. 2014 Jul 1:120(13):1914-6. doi: 10.1002/cncr.28695. Epub 2014 Mar 28     [PubMed PMID: 24687615]

[3]

de Micheli A. [The tobacco in the light of history and medicine]. Archivos de cardiologia de Mexico. 2015 Oct-Dec:85(4):318-22. doi: 10.1016/j.acmx.2014.12.012. Epub 2015 Mar 10     [PubMed PMID: 25769236]

[4]

Park-Lee E, Ren C, Cooper M, Cornelius M, Jamal A, Cullen KA. Tobacco Product Use Among Middle and High School Students - United States, 2022. MMWR. Morbidity and mortality weekly report. 2022 Nov 11:71(45):1429-1435. doi: 10.15585/mmwr.mm7145a1. Epub 2022 Nov 11     [PubMed PMID: 36355596]

[5]

Gentzke AS, Wang TW, Cornelius M, Park-Lee E, Ren C, Sawdey MD, Cullen KA, Loretan C, Jamal A, Homa DM. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002). 2022 Mar 11:71(5):1-29. doi: 10.15585/mmwr.ss7105a1. Epub 2022 Mar 11     [PubMed PMID: 35271557]

[6]

Boccio CM, Meldrum RC, Jackson DB. Adverse childhood experiences and adolescent nicotine and marijuana vaping: Findings from a statewide sample of Florida youth. Preventive medicine. 2022 Jan:154():106866. doi: 10.1016/j.ypmed.2021.106866. Epub 2021 Nov 2     [PubMed PMID: 34740675]

[7]

Gowing LR, Ali RL, Allsop S, Marsden J, Turf EE, West R, Witton J. Global statistics on addictive behaviours: 2014 status report. Addiction (Abingdon, England). 2015 Jun:110(6):904-19. doi: 10.1111/add.12899. Epub     [PubMed PMID: 25963869]

[8]

Cornelius ME, Loretan CG, Jamal A, Davis Lynn BC, Mayer M, Alcantara IC, Neff L. Tobacco Product Use Among Adults - United States, 2021. MMWR. Morbidity and mortality weekly report. 2023 May 5:72(18):475-483. doi: 10.15585/mmwr.mm7218a1. Epub 2023 May 5     [PubMed PMID: 37141154]

[9]

Wills L, Ables JL, Braunscheidel KM, Caligiuri SPB, Elayouby KS, Fillinger C, Ishikawa M, Moen JK, Kenny PJ. Neurobiological Mechanisms of Nicotine Reward and Aversion. Pharmacological reviews. 2022 Jan:74(1):271-310. doi: 10.1124/pharmrev.121.000299. Epub     [PubMed PMID: 35017179]

[10]

Alexandrov LB, Ju YS, Haase K, Van Loo P, Martincorena I, Nik-Zainal S, Totoki Y, Fujimoto A, Nakagawa H, Shibata T, Campbell PJ, Vineis P, Phillips DH, Stratton MR. Mutational signatures associated with tobacco smoking in human cancer. Science (New York, N.Y.). 2016 Nov 4:354(6312):618-622     [PubMed PMID: 27811275]

[11]

Kovac JR, Khanna A, Lipshultz LI. The effects of cigarette smoking on male fertility. Postgraduate medicine. 2015 Apr:127(3):338-41. doi: 10.1080/00325481.2015.1015928. Epub 2015 Feb 19     [PubMed PMID: 25697426]

[12]

Budani MC, Fensore S, Di Marzio M, Tiboni GM. Cigarette smoking impairs clinical outcomes of assisted reproductive technologies: A meta-analysis of the literature. Reproductive toxicology (Elmsford, N.Y.). 2018 Sep:80():49-59. doi: 10.1016/j.reprotox.2018.06.001. Epub 2018 Jun 12     [PubMed PMID: 29906539]

[13]

Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology. 2004 May 19:43(10):1731-7     [PubMed PMID: 15145091]

[14]

Balbo S, Turesky RJ, Villalta PW. DNA adductomics. Chemical research in toxicology. 2014 Mar 17:27(3):356-66. doi: 10.1021/tx4004352. Epub 2014 Feb 25     [PubMed PMID: 24437709]

[15]

Miller EC. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer research. 1978 Jun:38(6):1479-96     [PubMed PMID: 348302]

[16]

Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. International journal of environmental research and public health. 2009 Jan:6(1):209-24. doi: 10.3390/ijerph6010209. Epub 2009 Jan 9     [PubMed PMID: 19440278]

[17]

Li Y, Lin H, Li Y, Cao J. Association between socio-psycho-behavioral factors and male semen quality: systematic review and meta-analyses. Fertility and sterility. 2011 Jan:95(1):116-23. doi: 10.1016/j.fertnstert.2010.06.031. Epub 2010 Aug 2     [PubMed PMID: 20674912]

[18]

Firns S, Cruzat VF, Keane KN, Joesbury KA, Lee AH, Newsholme P, Yovich JL. The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data. Reproductive biology and endocrinology : RB&E. 2015 Dec 16:13():134. doi: 10.1186/s12958-015-0133-x. Epub 2015 Dec 16     [PubMed PMID: 26669322]

[19]

Pereira PP, Da Mata FA, Figueiredo AC, de Andrade KR, Pereira MG. Maternal Active Smoking During Pregnancy and Low Birth Weight in the Americas: A Systematic Review and Meta-analysis. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2017 May 1:19(5):497-505. doi: 10.1093/ntr/ntw228. Epub     [PubMed PMID: 28403455]

[20]

Zhang L, Wang XH, Zheng XM, Liu TZ, Zhang WB, Zheng H, Chen MF. Maternal gestational smoking, diabetes, alcohol drinking, pre-pregnancy obesity and the risk of cryptorchidism: a systematic review and meta-analysis of observational studies. PloS one. 2015:10(3):e0119006. doi: 10.1371/journal.pone.0119006. Epub 2015 Mar 23     [PubMed PMID: 25798927]

[21]

Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tobacco control. 2001 Jun:10(2):189-95     [PubMed PMID: 11387543]

[22]

Yano M, Miura S, Shiga Y, Miyase Y, Suematsu Y, Norimatsu K, Nakamura A, Adachi S, Nishikawa H, Saku K. Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography. Heart and vessels. 2016 Jul:31(7):1061-8. doi: 10.1007/s00380-015-0716-7. Epub 2015 Jul 18     [PubMed PMID: 26187325]

[23]

Jaén Díaz JI, de Castro Mesa C, Gontán García-Salamanca MJ, López de Castro F. [Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers]. Archivos de bronconeumologia. 2003 Dec:39(12):554-8     [PubMed PMID: 14636492]

[24]

Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, Freiberg MS. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study. Journal of the National Cancer Institute. 2018 Nov 1:110(11):1201-1207. doi: 10.1093/jnci/djy041. Epub     [PubMed PMID: 29788259]

[25]

Zee KY. Smoking and periodontal disease. Australian dental journal. 2009 Sep:54 Suppl 1():S44-50. doi: 10.1111/j.1834-7819.2009.01142.x. Epub     [PubMed PMID: 19737267]

[26]

Mineshita M, Kida H, Handa H, Nishine H, Furuya N, Inoue T, Matsuoka S, Miyazawa T. Regional Lung Sound Asynchrony in Chronic Obstructive Pulmonary Disease Patients. Respiration; international review of thoracic diseases. 2016:92(4):252-257     [PubMed PMID: 27626282]

[27]

Linneberg A, Jacobsen RK, Skaaby T, Taylor AE, Fluharty ME, Jeppesen JL, Bjorngaard JH, Åsvold BO, Gabrielsen ME, Campbell A, Marioni RE, Kumari M, Marques-Vidal P, Kaakinen M, Cavadino A, Postmus I, Ahluwalia TS, Wannamethee SG, Lahti J, Räikkönen K, Palotie A, Wong A, Dalgård C, Ford I, Ben-Shlomo Y, Christiansen L, Kyvik KO, Kuh D, Eriksson JG, Whincup PH, Mbarek H, de Geus EJ, Vink JM, Boomsma DI, Smith GD, Lawlor DA, Kisialiou A, McConnachie A, Padmanabhan S, Jukema JW, Power C, Hyppönen E, Preisig M, Waeber G, Vollenweider P, Korhonen T, Laatikainen T, Salomaa V, Kaprio J, Kivimaki M, Smith BH, Hayward C, Sørensen TI, Thuesen BH, Sattar N, Morris RW, Romundstad PR, Munafò MR, Jarvelin MR, Husemoen LL. Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circulation. Cardiovascular genetics. 2015 Dec:8(6):832-41. doi: 10.1161/CIRCGENETICS.115.001225. Epub 2015 Nov 4     [PubMed PMID: 26538566]

[28]

York NL, Kane C, Beaton K, Keown B, Mcmahan S. Identifying Barriers to Hospitalized Patients' Participation in a Free Smoking Cessation Support Program. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses. 2017 Jan:26(1):25-32     [PubMed PMID: 30351571]

[29]

Sweet L, Brasky TM, Cooper S, Doogan N, Hinton A, Klein EG, Nagaraja H, Quisenberry A, Xi W, Wewers ME. Quitting Behaviors Among Dual Cigarette and E-Cigarette Users and Cigarette Smokers Enrolled in the Tobacco User Adult Cohort. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2019 Feb 18:21(3):278-284. doi: 10.1093/ntr/nty222. Epub     [PubMed PMID: 30346585]

[30]

Halpern SD, Volpp KG. E-Cigarettes, Incentives, and Drugs for Smoking Cessation. The New England journal of medicine. 2018 Sep 6:379(10):992. doi: 10.1056/NEJMc1809349. Epub     [PubMed PMID: 30184454]

[31]

. Varenicline. Drugs and Lactation Database (LactMed®). 2006:():     [PubMed PMID: 30000748]

[32]

Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet (London, England). 2016 Jun 18:387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22     [PubMed PMID: 27116918]

[33]

Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S, Wharakura MK, Lees T, Cubillos Gutierrez H, Jones B, Bullen C. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction (Abingdon, England). 2021 Oct:116(10):2847-2858. doi: 10.1111/add.15489. Epub 2021 May 4     [PubMed PMID: 33761149]

[34]

King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. Journal of clinical psychopharmacology. 2012 Oct:32(5):630-6. doi: 10.1097/JCP.0b013e3182676956. Epub     [PubMed PMID: 22926596]

[35]

Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C. Cytisine versus nicotine for smoking cessation. The New England journal of medicine. 2014 Dec 18:371(25):2353-62. doi: 10.1056/NEJMoa1407764. Epub     [PubMed PMID: 25517706]

[36]

Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. American journal of preventive medicine. 2008 Aug:35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. Epub     [PubMed PMID: 18617085]

[37]

Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews. 2023 May 5:5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8. Epub 2023 May 5     [PubMed PMID: 37142273]

[38]

Robijn AL, Filion KB, Woodward M, Hsu B, Chow CK, Pearson SA, Jorm L, Falster MO, Havard A. Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events. Heart (British Cardiac Society). 2023 Jun 14:109(13):1016-1024. doi: 10.1136/heartjnl-2022-322170. Epub 2023 Jun 14     [PubMed PMID: 36878673]

[39]

Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. JAMA internal medicine. 2018 May 1:178(5):622-631. doi: 10.1001/jamainternmed.2018.0397. Epub     [PubMed PMID: 29630702]

[40]

Auer R, Schoeni A, Humair JP, Jacot-Sadowski I, Berlin I, Stuber MJ, Haller ML, Tango RC, Frei A, Strassmann A, Bruggmann P, Baty F, Brutsche M, Tal K, Baggio S, Jakob J, Sambiagio N, Hopf NB, Feller M, Rodondi N, Berthet A. Electronic Nicotine-Delivery Systems for Smoking Cessation. The New England journal of medicine. 2024 Feb 15:390(7):601-610. doi: 10.1056/NEJMoa2308815. Epub     [PubMed PMID: 38354139]

[41]

Turner E, Jones M, Vaz LR, Coleman T. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2019 Jul 17:21(8):1001-1010. doi: 10.1093/ntr/nty055. Epub     [PubMed PMID: 29579233]

[42]

Choi SKY, Tran DT, Kemp-Casey A, Preen DB, Randall D, Einarsdottir K, Jorm LR, Havard A. The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2021 Aug 29:23(10):1664-1672. doi: 10.1093/ntr/ntab063. Epub     [PubMed PMID: 34398235]

[43]

Pedersen L, Petronis KR, Nørgaard M, Mo J, Frøslev T, Stephansson O, Granath F, Kieler H, Sørensen HT. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden. Pharmacoepidemiology and drug safety. 2020 Jan:29(1):94-102. doi: 10.1002/pds.4894. Epub 2019 Nov 11     [PubMed PMID: 31713302]

[44]

Barboza J. Pharmaceutical strategies for smoking cessation during pregnancy. Expert opinion on pharmacotherapy. 2018 Dec:19(18):2033-2042. doi: 10.1080/14656566.2018.1538353. Epub 2018 Oct 29     [PubMed PMID: 30332554]

[45]

Elfandi S, Poudyal H. Tobacco Cessation Curriculum in Medical Schools: a Scoping Review. Journal of cancer education : the official journal of the American Association for Cancer Education. 2023 Oct:38(5):1614-1623. doi: 10.1007/s13187-023-02309-5. Epub 2023 May 16     [PubMed PMID: 37188986]

[46]

Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. The New England journal of medicine. 2013 Jan 24:368(4):341-50. doi: 10.1056/NEJMsa1211128. Epub     [PubMed PMID: 23343063]

[47]

Holla N, Brantley E, Ku L. Physicians' Recommendations to Medicaid Patients About Tobacco Cessation. American journal of preventive medicine. 2018 Dec:55(6):762-769. doi: 10.1016/j.amepre.2018.07.013. Epub 2018 Oct 19     [PubMed PMID: 30344039]

[48]

Komiyama M, Ozaki Y, Wada H, Yamakage H, Satoh-Asahara N, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa K. The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan. Trials. 2018 Oct 4:19(1):538. doi: 10.1186/s13063-018-2919-6. Epub 2018 Oct 4     [PubMed PMID: 30286787]

[49]

Duffy SA, Ronis DL, Karvonen-Gutierrez CA, Ewing LA, Dalack GW, Smith PM, Carmody TP, Hicks T, Hermann C, Reeves P, Flanagan P. Effectiveness of the tobacco tactics program in the Department of Veterans Affairs. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2014 Oct:48(2):265-74. doi: 10.1007/s12160-014-9605-z. Epub     [PubMed PMID: 24823842]

[50]

Duffy SA, Ignacio RV, Kim HM, Geraci MC, Essenmacher CA, Hall SV, Chow A, Pfeiffer PN, Sherman SE, Bohnert KM, Zivin K, Barnett PG. Effectiveness of tobacco cessation pharmacotherapy in the Veterans Health Administration. Tobacco control. 2019 Sep:28(5):540-547. doi: 10.1136/tobaccocontrol-2018-054473. Epub 2018 Sep 4     [PubMed PMID: 30181383]